Evidence map›Paper›PMID 18430993›Full record

ArticleJournal of Alzheimer's disease : JAD2008

Multiple SNPs within and surrounding the apolipoprotein E gene influence cerebrospinal fluid apolipoprotein E protein levels.

Lynn M Bekris, Steven P Millard, Nichole M Galloway, Simona Vuletic, John J Albers, Ge Li, Douglas R Galasko, Charles DeCarli, Martin R Farlow, Chris M Clark and 6 more

Abstract read
In one paragraph

Article in Journal of Alzheimer's disease : JAD, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
4.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 87 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Pathways to Alzheimer's Disease: The Intersecting Roles of Clusterin and Apolipoprotein E in Amyloid-β Regulation and Neuronal Health.Pathophysiology : the official journal of the International Society for Pathophysiology · 2024
    Review
  6. Article
  7. Review
  8. Article
  9. Genes · 2021
    Article
  10. Article
  11. Frontiers in aging neuroscience · 2021
    Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. The Role of Upregulated APOE in Alzheimer's Disease Etiology.Journal of Alzheimer's disease & Parkinsonism · 2016
    Article
  18. Article
  19. Cerebrospinal fluid Aβ42 levels and APP processing pathway genes in Parkinson's disease.Movement disorders : official journal of the Movement Disorder Society · 2015
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 11 institutions in 1 country.

Lynn M BekrisGeriatric Research, Education, and Clinical Center (GRECC), VA Puget Sound Health Care System, Seattle, WA 98108, USA. lbekris@u.washington.edu
Steven P Millard
Nichole M Galloway
Simona Vuletic
John J Albers
Ge Li
Douglas R Galasko
Charles DeCarli
Martin R Farlow
Chris M Clark
Joseph F Quinn
Jeffrey A Kaye
Gerard D Schellenberg
Debby Tsuang
Elaine R Peskind
Chang-En Yu
University of Washington · USMental Illness Research, Education and Clinical Centers · USVA Puget Sound Health Care System · USGeriatric Research Education and Clinical Center · USIndiana University School of MedicineInstitute on Aging · USOregon Health & Science University · USPortland VA Medical Center · USUniversity of California, Davis · USUniversity of California San Diego Medical Center · USVA Northwest Network · US

Funding

NATIONAL ALZHEIMERS COORDINATING CENTER (NACC)U01AG016976 · NIA · UNIVERSITY OF WASHINGTON · PI KUKULL, WALTER ANTHONY · 1999 to 2020
$72.8M
THERAPEUTIC EFFECTS OF INTRA-NASAL INSULIN DETEMIRP50AG005136 · NIA · UNIVERSITY OF WASHINGTON · PI JAYADEY, SUMAN · 1985 to 2019
$57.2M
UC Davis Alzheimer's Disease Core CenterP30AG010129 · NIA · UNIVERSITY OF CALIFORNIA DAVIS · PI DECARLI, CHARLES · 1991 to 2020
$28.3M
Outreach, Recruitment and Education CoreP30AG008017 · NIA · OREGON HEALTH & SCIENCE UNIVERSITY · PI DODGE, HIROKO HAYAMA · 1990 to 2019
$27.7M
Serum Amyloid and Inflammation in AtherogenesisP01HL030086 · NHLBI · UNIVERSITY OF WASHINGTON · PI HEINECKE, JAY W · 1985 to 2009
$14.7M
NEUROBEHAVIOR, NEUROENDOCRINOLOGY, AND GENETICS OF ADT32AG000258 · NIA · UNIVERSITY OF WASHINGTON · PI MONTINE, THOMAS J · 1999 to 2013
$4.7M
Dementia with Lewy Bodies: A Collaborative StudyR01NS048595 · NINDS · UNIVERSITY OF WASHINGTON · PI MONTINE, THOMAS J · 2003 to 2007
$2.7M
APOE Gene-Based Haplotype Study in Alzeheimer's DiseaseR21AG024486 · NIA · UNIVERSITY OF WASHINGTON · PI YU, CHANG-EN · 2004 to 2005
$225k
NHLBI NIH HHS P01 HL030086NHLBI NIH HHS P01HL30086NIA NIH HHS 5T32AG000258-07NIA NIH HHS AG05136NIA NIH HHS AG08017NIA NIH HHS P30 AG008017NIA NIH HHS P30 AG010129NIA NIH HHS P50 AG005136NIA NIH HHS R21 AG024486NIA NIH HHS R21 AG24486-01NIA NIH HHS T32 AG000258NIA NIH HHS U01 AG016976NINDS NIH HHS R01 NS048595NINDS NIH HHS R01 NS48595
6 · The paper itself

Abstract

The epsilon4 allele of the apolipoprotein E gene (APOE) is associated with increased risk and earlier age at onset in late onset Alzheimer's disease (AD). Other factors, such as expression level of apolipoprotein E protein (apoE), have been postulated to modify the APOE related risk of developing AD. Multiple loci in and outside of APOE are associated with a high risk of AD. The aim of this exploratory hypothesis generating investigation was to determine if some of these loci predict cerebrospinal fluid (CSF) apoE levels in healthy non-demented subjects. CSF apoE levels were measured from healthy non-demented subjects 21-87 years of age (n=134). Backward regression models were used to evaluate the influence of 21 SNPs, within and surrounding APOE, on CSF apoE levels while taking into account age, gender, APOE epsilon4 and correlation between SNPs (linkage disequilibrium). APOE epsilon4 genotype does not predict CSF apoE levels. Three SNPs within the TOMM40 gene, one APOE promoter SNP and two SNPs within distal APOE enhancer elements (ME1 and BCR) predict CSF apoE levels. Further investigation of the genetic influence of these loci on apoE expression levels in the central nervous system is likely to provide new insight into apoE regulation as well as AD pathogenesis.

Indexed as

AdultAgedAged, 80 and overAlzheimer DiseaseApolipoprotein E4Apolipoproteins EDNA PrimersEnhancer Elements, GeneticFemaleHumansLinkage DisequilibriumMaleMembrane Transport ProteinsMiddle AgedMitochondrial Precursor Protein Import Complex ProteinsNeuropsychological TestsApolipoprotein E4Apolipoproteins EDNA PrimersMembrane Transport ProteinsMitochondrial Precursor Protein Import Complex ProteinsTOMM40 protein, human

Identifiers

PMID18430993
PMCPMC3192652
OpenAlexW1648176606

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.